Niagara Falls, NY – July 31, 2023 (GLOBE NEWSWIRE) – Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company that manufactures, sells and services PET imaging systems and clinical services, is pleased to announce that in combination with its new Business Cooperative Partnership with Shenyang Intelligent Neuclear Medical Technology Co, a wholly owned subsidiary of, Neusoft Medical Systems, Positron has agreed on terms to purchase the current inventory from the Company’s PET Joint Venture partner, Neusoft Positron Medical Systems. Positron will acquire six (6) Attrius PET systems and all Attrius PET system components held in inventory, with an estimated value of $6 million dollars. The Attrius components inventory provides a full spectrum of parts which will service Attrius PET customers over the next decade.
Positron has identified multiple nuclear cardiology practices seeking to purchase Attrius dedicated PET only systems with several sales proposals currently in the process of acceptance. Positron has introduced a “Lease to Own/Services Program” which provides an Attrius PET System and all Clinical & Technical Services for one price per month. The model lease is based on a 4-year term with the system’s ownership transferred to the customer upon completion of the lease, which will also include an annual full services agreement at a guaranteed set price. Positron’s Lease to Own/Services Program offers a zero upfront Capex expense providing the most attractive and viable operational model for nuclear imaging cardiac PET practices in the industry. Positron anticipates acceptance of several Attrius systems with customers before the launch of its new PET-CT system in the coming months with most expected to participate in Positron’s Attrius Lease to Own/Services Program.
Adel Abdullah, President of Positron stated: Positron’s Attrius dedicated PET only system is a tremendous tool for advanced cardiac studies and diagnostics, and we are pleased for our customers to take advantage of our Attrius, services, training, and our new Lease to Own Program. Mr. Abdullah continued, Positron’s objectives are fully aligned with our physicians’ and practices that demand to deliver the best quality nuclear imaging care to its patients, which can be achieved by providing the most value through offering superior images, clinical services, and cost-effective pricing. Moving forward we expect to be part of many innovative solutions for physicians, practices, and hospitals that we believe will accelerate the adoption of the PET modality and future growth of Positron.